07:00 , Sep 19, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Nuclear assembly factor 1 ribonucleoprotein (NAF1); CDGSH iron sulfur domain 1 (CISD1; mitoNEET) In vitro and mouse studies suggest inhibiting mitochondrial NAF1 or...